DB Wealth Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$61.4K Hold
396
0.03% 146
2023
Q3
$59K Sell
396
-50
-11% -$7.34K 0.04% 149
2023
Q2
$60.1K Hold
446
0.04% 141
2023
Q1
$71.1K Hold
446
0.04% 126
2022
Q4
$72.1K Hold
446
0.05% 124
2022
Q3
$60K Hold
446
0.04% 138
2022
Q2
$68K Hold
446
0.05% 132
2022
Q1
$72K Buy
446
+307
+221% +$44.6K 0.04% 142
2021
Q4
$19K Hold
139
0.01% 229
2021
Q3
$15K Sell
139
-50
-26% -$5.71K 0.01% 237
2021
Q2
$21K Hold
189
0.01% 223
2021
Q1
$20K Hold
189
0.01% 232
2020
Q4
$20K Buy
+189
New +$18.2K 0.01% 223

Other funds holding ABBV

DB Wealth Management Group's ABBV Position: Q4 2023 in Review

DB Wealth Management Group held its AbbVie (ABBV) position steady in Q4 2023 at 396 shares worth $61.4K. The position accounts for 0.03% of the portfolio, ranked #146.

DB Wealth Management Group first reported a position in ABBV in Q4 2020 and has held it in 13 quarters since. The position peaked at $72.1K in Q4 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • DB Wealth Management Group held 396 shares of AbbVie worth $61.4K as of Q4 2023.
  • DB Wealth Management Group left its AbbVie share count unchanged in Q4 2023.
  • AbbVie made up 0.03% of DB Wealth Management Group's portfolio in Q4 2023, its #146 holding.
  • DB Wealth Management Group first reported a position in AbbVie in Q4 2020 and has held it in 13 quarters since.
  • DB Wealth Management Group's AbbVie position peaked at $72.1K in Q4 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.